Category : Search result: Alderley Park

Cheshire Biotech Secures £4.5m for Brain Cancer Treatment

Alderley Park-based QV Bioelectronics has secured £4.5 million in funding to advance its world-first implantable device for treating glioblastoma brain cancer through clinical trials.